vs
Penumbra Inc（PEN）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
Penumbra Inc的季度营收约是LiveRamp Holdings, Inc.的1.8倍（$385.4M vs $212.2M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 12.3%，领先6.5%），Penumbra Inc同比增速更快（22.1% vs 8.6%），过去两年Penumbra Inc的营收复合增速更高（17.6% vs 11.1%）
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
PEN vs RAMP — 直观对比
营收规模更大
PEN
是对方的1.8倍
$212.2M
营收增速更快
PEN
高出13.6%
8.6%
净利率更高
RAMP
高出6.5%
12.3%
两年增速更快
PEN
近两年复合增速
11.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $385.4M | $212.2M |
| 净利润 | $47.3M | $39.9M |
| 毛利率 | 68.0% | 71.9% |
| 营业利润率 | 15.4% | 18.6% |
| 净利率 | 12.3% | 18.8% |
| 营收同比 | 22.1% | 8.6% |
| 净利润同比 | 40.6% | 255.7% |
| 每股收益（稀释后） | $1.20 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PENRAMP
| Q4 25 | $385.4M | $212.2M | ||
| Q3 25 | $354.7M | $199.8M | ||
| Q2 25 | $339.5M | $194.8M | ||
| Q1 25 | $324.1M | $188.7M | ||
| Q4 24 | $315.5M | $195.4M | ||
| Q3 24 | $301.0M | $185.5M | ||
| Q2 24 | $299.4M | $176.0M | ||
| Q1 24 | $278.7M | $171.9M |
净利润PENRAMP
| Q4 25 | $47.3M | $39.9M | ||
| Q3 25 | $45.9M | $27.4M | ||
| Q2 25 | $45.3M | $7.7M | ||
| Q1 25 | $39.2M | $-6.3M | ||
| Q4 24 | $33.7M | $11.2M | ||
| Q3 24 | $29.5M | $1.7M | ||
| Q2 24 | $-60.2M | $-7.5M | ||
| Q1 24 | $11.0M | $-5.4M |
毛利率PENRAMP
| Q4 25 | 68.0% | 71.9% | ||
| Q3 25 | 67.8% | 70.2% | ||
| Q2 25 | 66.0% | 70.1% | ||
| Q1 25 | 66.6% | 69.3% | ||
| Q4 24 | 66.8% | 71.9% | ||
| Q3 24 | 66.5% | 72.4% | ||
| Q2 24 | 54.4% | 70.6% | ||
| Q1 24 | 65.0% | 72.2% |
营业利润率PENRAMP
| Q4 25 | 15.4% | 18.6% | ||
| Q3 25 | 13.8% | 10.7% | ||
| Q2 25 | 12.0% | 3.7% | ||
| Q1 25 | 12.4% | -6.1% | ||
| Q4 24 | 13.6% | 7.5% | ||
| Q3 24 | 11.7% | 4.0% | ||
| Q2 24 | -27.0% | -3.0% | ||
| Q1 24 | 4.3% | -8.3% |
净利率PENRAMP
| Q4 25 | 12.3% | 18.8% | ||
| Q3 25 | 12.9% | 13.7% | ||
| Q2 25 | 13.3% | 4.0% | ||
| Q1 25 | 12.1% | -3.3% | ||
| Q4 24 | 10.7% | 5.7% | ||
| Q3 24 | 9.8% | 0.9% | ||
| Q2 24 | -20.1% | -4.3% | ||
| Q1 24 | 3.9% | -3.1% |
每股收益（稀释后）PENRAMP
| Q4 25 | $1.20 | $0.62 | ||
| Q3 25 | $1.17 | $0.42 | ||
| Q2 25 | $1.15 | $0.12 | ||
| Q1 25 | $1.00 | $-0.10 | ||
| Q4 24 | $0.88 | $0.17 | ||
| Q3 24 | $0.75 | $0.03 | ||
| Q2 24 | $-1.55 | $-0.11 | ||
| Q1 24 | $0.28 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $186.9M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.4B | $962.3M |
| 总资产 | $1.8B | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PENRAMP
| Q4 25 | $186.9M | $403.4M | ||
| Q3 25 | $321.0M | $376.9M | ||
| Q2 25 | $421.8M | $371.1M | ||
| Q1 25 | $376.1M | $420.8M | ||
| Q4 24 | $324.4M | $384.3M | ||
| Q3 24 | $280.5M | $348.4M | ||
| Q2 24 | $288.3M | $342.7M | ||
| Q1 24 | $223.1M | $368.9M |
股东权益PENRAMP
| Q4 25 | $1.4B | $962.3M | ||
| Q3 25 | $1.4B | $943.8M | ||
| Q2 25 | $1.3B | $947.8M | ||
| Q1 25 | $1.2B | $948.9M | ||
| Q4 24 | $1.2B | $957.7M | ||
| Q3 24 | $1.1B | $932.1M | ||
| Q2 24 | $1.2B | $951.9M | ||
| Q1 24 | $1.2B | $949.1M |
总资产PENRAMP
| Q4 25 | $1.8B | $1.3B | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.5B | $1.3B | ||
| Q3 24 | $1.5B | $1.2B | ||
| Q2 24 | $1.5B | $1.2B | ||
| Q1 24 | $1.6B | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $86.5M | — |
| 自由现金流经营现金流 - 资本支出 | $68.0M | — |
| 自由现金流率自由现金流/营收 | 17.7% | — |
| 资本支出强度资本支出/营收 | 4.8% | 0.1% |
| 现金转化率经营现金流/净利润 | 1.83× | — |
| 过去12个月自由现金流最近4个季度 | $174.9M | — |
8季度趋势，按日历期对齐
经营现金流PENRAMP
| Q4 25 | $86.5M | — | ||
| Q3 25 | $58.3M | $57.4M | ||
| Q2 25 | $44.9M | $-15.8M | ||
| Q1 25 | $49.0M | — | ||
| Q4 24 | $51.1M | $45.1M | ||
| Q3 24 | $56.5M | $55.6M | ||
| Q2 24 | $22.6M | $-9.3M | ||
| Q1 24 | $38.3M | — |
自由现金流PENRAMP
| Q4 25 | $68.0M | — | ||
| Q3 25 | $42.0M | $56.8M | ||
| Q2 25 | $29.4M | $-16.2M | ||
| Q1 25 | $35.5M | — | ||
| Q4 24 | $45.7M | $44.8M | ||
| Q3 24 | $51.0M | $55.4M | ||
| Q2 24 | $18.1M | $-9.6M | ||
| Q1 24 | $32.5M | — |
自由现金流率PENRAMP
| Q4 25 | 17.7% | — | ||
| Q3 25 | 11.8% | 28.4% | ||
| Q2 25 | 8.7% | -8.3% | ||
| Q1 25 | 11.0% | — | ||
| Q4 24 | 14.5% | 22.9% | ||
| Q3 24 | 16.9% | 29.8% | ||
| Q2 24 | 6.0% | -5.4% | ||
| Q1 24 | 11.7% | — |
资本支出强度PENRAMP
| Q4 25 | 4.8% | 0.1% | ||
| Q3 25 | 4.6% | 0.3% | ||
| Q2 25 | 4.6% | 0.2% | ||
| Q1 25 | 4.2% | 0.2% | ||
| Q4 24 | 1.7% | 0.1% | ||
| Q3 24 | 1.8% | 0.1% | ||
| Q2 24 | 1.5% | 0.1% | ||
| Q1 24 | 2.1% | 1.0% |
现金转化率PENRAMP
| Q4 25 | 1.83× | — | ||
| Q3 25 | 1.27× | 2.09× | ||
| Q2 25 | 0.99× | -2.04× | ||
| Q1 25 | 1.25× | — | ||
| Q4 24 | 1.52× | 4.02× | ||
| Q3 24 | 1.91× | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.48× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PEN
| Thrombectomy | $254.7M | 66% |
| Other | $130.7M | 34% |
RAMP
暂无分部数据
